Preparation method and application of hollow copper-sulfur tungsten nanozyme with nuclear targeted radiotherapy sensitization

Through the preparation of targeted nuclear radiation-sensitizing hollow thiotungsten copper nanoenzyme, the problems of insufficient radiation energy deposition and tumor antioxidant stress in existing radiotherapy technologies are solved, and the radiation damage at tumor sites is effectively enhanced at low doses and improve the oxidative stress environment, significantly improving the tumor treatment effect.

CN116531519BInactive Publication Date: 2024-11-15ARMY MEDICAL UNIV
0 Cites 0 Cited by

Patent Information

Application Number
CN202310352086.3
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2023-04-04
Publication Date
2024-11-15
Estimated Expiration
Not applicable · inactive patent

Smart Images

  • Figure CN116531519B_ABST
    Figure CN116531519B_ABST
Patent Text Reader

Abstract

The present invention relates to a preparation method and application of a hollow sulfur-tungsten copper nanozyme with nuclear targeted radiotherapy sensitization. The method comprises the following steps: uniformly dispersing cuprous oxide nanoparticles and glucose by ultrasonication, adding sodium tungstate and thioacetamide, stirring and mixing, placing the mixture in a high-temperature and high-pressure reactor at 200°C for reaction for 24 hours, obtaining mixed nanoparticles, and centrifuging and washing the mixture to obtain a hollow sulfur-tungsten copper nanozyme Cu. 2 WS 4 PEG and hollow copper tungsten sulfate nanozyme Cu 2 WS 4 After mixing and ultrasonic dispersion in an ice bath for 2 h, the copper tungsten sulfide nanozyme Cu with carboxyl groups was obtained by centrifugal washing. 2 WS 4 The hollow sulfur-tungsten copper nanozyme prepared by this method has the properties of nuclear targeting and radiosensitization, and can be used for multiple radiosensitization treatment of tumors.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the field of chemical drugs, and in particular to a preparation method and application of a hollow sulfur-tungsten copper nanozyme with nuclear targeted radiotherapy sensitization. Background Art

[0002] Cancer is a powerful enemy that takes away human life and health. Modern effective treatments for cancer include surgery, radiotherapy, chemotherapy, endocrine therapy, and biological therapy. It is reported that most cancer patients receive either radiotherapy alone or radiotherapy combined with other types of therapy. Radiotherapy (RT) is the mainstream strategy for the current clinical treatment of cancer. High-energy radiation such as x-rays or gamma rays can directly ionize DNA molecules or indirectly interact with water to form reactive oxygen species (ROS) such as hydroxyl radicals (·OH) that induce cell apoptosis, ferroptosis, and pyroptosis. However, there are still the following problems: high ionizing radiation inevitably damages normal tissues around the tumor; cancer cells are insensitive to ionizing radiation due to the anti-oxidative stress capacity of the tumor microenvironment; traditional small molecule radiotherapy sensitizers have fast metabolism and low targeting efficiency, making it difficult for radiotherapy to achieve ideal radiotherapy effects. Therefore, people expect to effectively reduce the irradiation dose to reduce damage to normal tissues and effectively enhance the ionizing radiation energy deposition at the tumor site. The development of nanomedicine, especially the tumor radiotherapy sensitization technology based on nanosensitizers, provides a new idea for the treatment of cancer. Various nanoparticles containing high-Z group elements, including gold (Au), hafnium (Hf), and bismuth (Bi), have been explored as possible radiosensitizers due to their X-ray photon capture cross-sections and Compton scattering effects. These nanomaterials can enhance X-ray energy deposition in tumors, thereby achieving a higher RT therapeutic index at relatively low X-ray doses. Various types of nanoparticles with controllable morphology and size and easily modified surfaces, such as CuS, Bi2S3 nanorods, and carbon-based nanomaterials, accumulate in the tumor area through passive targeting by the EPR effect or active targeting mediated by modified ligands-receptors, or a combination of the two, effectively enhancing radiation dose deposition.

[0003] Nanozymes have successfully replaced the catalytic effect of traditional enzymes by effectively mimicking the catalytic sites of natural enzymes or hiding multivalent elements in the reaction. Recent extensive research has focused on designing various nanozyme systems to make nanozymes respond to one or more substrates in a customized manner. In addition, nanozymes can improve the catalytic effect through different external stimuli, including magnetic fields, light, ultrasound, and heat. In general, these factors can be combined with each other to maximize the diagnostic and therapeutic effects of nanozymes on different diseases in a biomedical environment. Some nanozymes also have effects such as CT, MRI, and photoacoustic imaging. In addition, more and more studies have shown that nanozymes kill cancer cells by in situ catalyzing reactive oxygen species (ROS) and other substances produced by tumor microenvironment substrates H2O2, which will induce immunogenic death of cancer cells, thereby combining with immune checkpoint inhibitors to achieve synergistic effects of multiple treatment methods, showing good effects on tumor treatment and anti-metastasis. Therefore, the applicant integrates the catalytic properties of nanozymes and their inherent physicochemical properties to design and synthesize a method for preparing hollow sulfur tungsten copper nanozymes with radiosensitization effects that target nuclear targets. Currently, a small number of nanozymes containing high-Z group elements have been reported to have radiotherapy sensitization effects, but there are few reports of nanozymes that can target the cell nucleus and accurately increase damage to cancer cell DNA.

[0004] Due to the anti-oxidative stress capacity of the tumor microenvironment, cancer cells are insensitive to ionizing radiation. Traditional small molecule radiotherapy sensitizers have rapid metabolism and low targeting efficiency, making it difficult for radiotherapy to achieve ideal therapeutic effects. Summary of the invention

[0005] The purpose of the present invention is to provide a preparation method and application of a hollow copper tungsten disulfide nanozyme with nuclear targeting and radiotherapy sensitization. The hollow copper tungsten disulfide nanozyme prepared by the method has the performance of nuclear targeting and radiotherapy sensitization, and can be used for multiple radiotherapy sensitization treatment of tumors.

[0006] The technical solution of the present invention is:

[0007] The preparation method of hollow sulfur-tungsten copper nanozyme comprises the following steps:

[0008] 1) Screening of copper tungsten sulfate nanozymes

[0009] The cuprous oxide nanoparticles and glucose were evenly dispersed by ultrasonication, and then sodium tungstate and thioacetamide were added and stirred to mix, and then the above solution was placed in a high temperature and high pressure reactor at 200°C for 24 hours to obtain mixed nanoparticles, and hollow sulfur tungsten copper nanozyme Cu2WS4 was obtained after centrifugal washing;

[0010] 2) Carboxyl modification of Cu2WS4 nanozyme

[0011] PEG was mixed with hollow copper tungsten sulfate nanozyme Cu2WS4, and after ultrasonic dispersion in an ice bath for 2 hours, copper tungsten sulfate nanozyme Cu2WS4-PEG with carboxyl groups was obtained by centrifugal washing.

[0012] In step 1), the molar ratio of cuprous oxide nanoparticles to glucose is 1-10:1-20.

[0013] In step 1), the molar ratio of sodium tungstate to thioacetyl is 5-1:1-20.

[0014] In step 1), the Cu2WS4 targets the cell nucleus and has radiosensitization.

[0015] In step 2), the molar ratio of PEG to hollow copper tungsten sulfate nanozyme Cu2WS4 is 1:1.

[0016] The concentration of PEG in step 2) is 10 mg / mL.

[0017] The hollow copper tungsten sulfate nanozyme is used in the preparation of a sensitizer for treating tumors.

[0018] The present invention will fully explore the physical and chemical properties of nanomaterials, especially their enzyme-like activity and organically combine it with radiotherapy, and realize the combination of multiple response enhanced radiotherapy and immunotherapy through the element selection and structural design of nanozyme materials. Nanozymes containing high Z group elements can effectively enhance X-ray deposition, and their X-ray enhanced peroxidase-like activity can effectively produce reactive oxygen to cause oxidative damage to tumor cells, causing cell apoptosis and necrosis, etc., and their peroxidase activity can effectively consume GSH to improve the oxidative stress of the cancer cell microenvironment and further achieve radiosensitization, thereby realizing multiple radiosensitization therapy for tumors. BRIEF DESCRIPTION OF THE DRAWINGS

[0019] In order to make the purpose, technical solution and beneficial effects of the present invention clearer, the present invention provides the following drawings:

[0020] Figure 1 Schematic diagram of the synthesis and action of the hollow copper tungsten sulfur nanozyme with radiotherapy sensitization effect targeting nuclei in Example 1 of the present invention.

[0021] Figure 2 This is a TEM image of the hollow sulfur-tungsten-copper nanozyme with radiotherapy sensitization effect targeting the nucleus described in the present invention.

[0022] Figure 3 This is a characterization diagram of the glutathione oxidase activity of the hollow sulfur-tungsten copper nanozyme that targets the nucleus and has a radiotherapy sensitization effect and can consume GSH as described in the present invention.

[0023] Figure 4This is a characterization diagram of the peroxidase activity of the hollow copper tungsten sulfur nanozyme with targeted nucleus and radiotherapy sensitization effect described in the present invention using TMB as the reaction substrate.

[0024] Figure 5 This is a diagram of the in vivo anti-tumor effect of the hollow sulfur-tungsten copper nanozyme with radiosensitization effect targeting the nucleus described in the present invention.

[0025] Figure 6 This is the distribution of the hollow copper tungsten sulfur nanozyme with targeted nuclear radiosensitization effect in the nucleus of mouse breast cancer cells (4T1). DETAILED DESCRIPTION

[0026] The reagents used in this example are all AR analytical grade reagents from Aladdin Reagent Company.

[0027] Example 1 Preparation and screening of hollow copper tungsten sulfate nanozymes (see Figure 1 )

[0028] 1) First, cuprous oxide nanoparticles and glucose are added to a conical flask containing ethylene glycol, and ultrasonically dispersed for 30 minutes, wherein the molar ratio of cuprous oxide nanoparticles to glucose is 1:120; then, sodium tungstate and thioacetamide are added to the above-mentioned conical flask and stirred evenly, wherein the molar ratio of sodium tungstate to thioacetamide is 5:1; then, the above-mentioned solution is placed in a high-temperature and high-pressure reactor, reacted at 200°C for 24 hours, and mixed nanoparticles are obtained. After centrifugation and water washing, hollow Cu2WS4 nanozymes with targeting cell nuclei and radiosensitization effect are obtained.

[0029] 2) Carboxyl modification of Cu2WS4 nanozyme: PEG and hollow Cu2WS4 nanozyme with targeted nuclear radiosensitization effect were mixed in a molar ratio of 1:1, and after ultrasonic dispersion in an ice bath for 2 hours, the hollow sulfur tungsten copper nanozyme Cu2WS4-PEG with targeted nuclear radiosensitization effect was obtained by centrifugal washing.

[0030] Example 2 Transmission electron microscopy experiment

[0031] The transmission electron microscopy (TEM) of the above-obtained copper tungsten sulfur nanozyme Cu2WS4-PEG is shown in Figure 2 ,TEM results show that the diameter of the nanoparticles is about 90nm.

[0032] Example 3 Glutathione oxidase activity experiment

[0033] After different concentrations of Cu2WS4 nanozymes (170, 85, 42, 20, 10, 0 mg / mL) were reacted with 4 mg / mL GSH solution at room temperature for 2 minutes, 4 mg / mL DTNB solution was added and reacted in the dark for 30 minutes. The ultraviolet absorption of the solution was detected at 412 nm, and then the proportion of GSH consumption was calculated. Figure 3 The figure shows the consumption of glutathione (GSH) by Cu2WS4 nanozymes at different concentrations, proving its glutathione oxidase activity: As can be seen from the figure, as the working concentration of Cu2WS4 nanozymes increases, more GSH is consumed. When the maximum concentration is 170μg / mL, 79% of glutathione can be consumed. This shows that Cu2WS4 nanozymes have glutathione oxidase activity.

[0034] Example 4 Peroxidase activity experiment

[0035] 10Mm 3,3',5,5'-tetramethylbenzidine (TMB) solution was reacted with different reactants in different groups for 5 minutes, and then the absorption curve was immediately detected by UV-visible spectrophotometer (grouping: Cu2WS4, Cu2WS4+H2O2, H2O2). Figure 4 The characteristic absorption of Cu2WS4 nanozyme catalyzing the oxidation of substrate TMB at 652nm proves its peroxidase activity. As shown in the figure: when Cu2WS4 nanozyme and hydrogen peroxide react with peroxidase substrate TMB separately, the product has no characteristic absorption at 652nm. When Cu2WS4 nanozyme and hydrogen peroxide act on peroxidase substrate TMB together, characteristic absorption of the product at 652nm can be observed, proving that Cu2WS4 has peroxidase activity.

[0036] Example 5: Targeting the cell nucleus

[0037] After culturing 20 μg / mL of Cu2WS4 nanozyme with 4T1 cells for 24 hours, the supernatant culture medium was discarded. The 4T1 cells that adhered to the bottom were collected after trypsin digestion and fixed with 2% glutaraldehyde solution. The internalization of Cu2WS4 nanozyme by 4T1 cells was observed by electron microscopy. The traces of Cu2WS4 nanozyme were observed in the 4T1 cell nucleus, indicating that Cu2WS4 nanozyme can enter the 4T1 cell nucleus, see Figure 5 .

[0038] Example 6 Tumor Inhibition Effect

[0039] Balb / c mice were depilated and 4T1 cells were inoculated in their right hind legs. The tumors grew to a volume of about 100 mm in about a week. 3 Afterwards, the mice were randomly divided into four groups: PBS, X, Cu2WS 4,Cu2WS4+X. The intravenous dose of Cu2WS4 was 20 mg / kg, and two irradiations (6 Gy) were given on the second and sixth days after administration. It can be seen from the figure that compared with other groups, Cu2WS4 nanozyme showed obvious tumor inhibition effect after X-ray irradiation. The tumor inhibition rates of the X-ray irradiation group and the Cu2WS4 nanozyme administration group were 54.2% and 21.5%, respectively. However, when the two acted synergistically, the tumor inhibition rate could reach 84.8%, indicating that Cu2WS4 nanozyme has radiosensitization effect, see Figure 6 .

[0040] Finally, it should be noted that the above preferred embodiments are only used to illustrate the technical solutions of the present invention rather than to limit it. Although the present invention has been described in detail through the above preferred embodiments, those skilled in the art should understand that various changes can be made in form and details without departing from the scope defined by the claims of the present invention.

Claims

1. A method for preparing a hollow copper tungsten sulfate nanozyme. It is characterized in that There are the following steps: 1) Screening of copper tungsten sulfate nanozymes The cuprous oxide nanoparticles and glucose were evenly dispersed by ultrasonication, and then sodium tungstate and thioacetamide were added, stirred and mixed, and placed in a high temperature and high pressure reactor at 200°C for 24 hours to obtain mixed nanoparticles. After centrifugation and water washing, hollow sulfur tungsten copper nanozyme Cu 2 WS 4 , the molar ratio of sodium tungstate and thioacetyl is 5~1:1~20; 2) Cu 2 WS 4 Carboxyl modification of nanozymes PEG was combined with hollow copper tungsten sulfate nanozyme Cu 2 WS 4 After mixing and ultrasonic dispersion in an ice bath for 2 h, the copper tungsten sulfide nanozyme Cu with carboxyl groups was obtained by centrifugal washing. 2 WS 4 -PEG; The Cu 2 WS 4 It is a nanozyme with the ability to target cancer cell nuclei and enhance radiotherapy sensitization.

2. The preparation method according to claim 1, Features: In step 1), the molar ratio of cuprous oxide nanoparticles to glucose is 1-10: 1-20.

3. The preparation method according to claim 1, Features: Step 2) PEG and hollow copper tungsten sulfate nanozyme Cu 2 WS 4 The molar ratio is 1:

1.

4. The preparation method according to claim 1, Features: The concentration of PEG in step 2) is 10 mg / mL.

5. Use of the hollow sulfur-tungsten copper nanozyme according to claim 1 in the preparation of a sensitizer for treating tumors.